# Voya Financial, Inc.: financial statements, quarterly

VOYA · NYSE · CIK 1535929 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/voya.md) · [Financials](/companies/voya/financials.md) · [Filings](/companies/voya/filings.md) · [Insiders](/companies/voya/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/voya/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [491](/filings/0001535929-24-000103.md) | [477 d](/filings/0001535929-26-000043.md) | [519](/filings/0001535929-25-000040.md) | [528](/filings/0001535929-25-000071.md) | [542](/filings/0001535929-25-000115.md) | [561 d](/filings/0001535929-26-000043.md) | [538](/filings/0001535929-26-000083.md) | [541](/filings/0001535929-26-000157.md) | [572](/filings/0001535929-25-000115.md) | [603 d](/filings/0001535929-26-000043.md) | [520](/filings/0001535929-26-000083.md) | [531](/filings/0001535929-26-000157.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(74.0)](/filings/0001535929-24-000103.md) | [(17.0) d](/filings/0001535929-26-000043.md) | [(1.0)](/filings/0001535929-25-000040.md) | [41.0](/filings/0001535929-25-000071.md) | [18.0](/filings/0001535929-25-000115.md) | [(1.0) d](/filings/0001535929-26-000043.md) | [22.0](/filings/0001535929-26-000083.md) | [27.0](/filings/0001535929-26-000157.md) | [35.0](/filings/0001535929-25-000115.md) | [20.0 d](/filings/0001535929-26-000043.md) | [35.0](/filings/0001535929-26-000083.md) | [16.0](/filings/0001535929-26-000157.md) |
| Net income | $m | [262](/filings/0001535929-24-000103.md) | [122 d](/filings/0001535929-26-000043.md) | [251](/filings/0001535929-25-000040.md) | [205](/filings/0001535929-25-000071.md) | [114](/filings/0001535929-25-000115.md) | [97.0 d](/filings/0001535929-26-000043.md) | [156](/filings/0001535929-26-000083.md) | [166](/filings/0001535929-26-000157.md) | [192](/filings/0001535929-25-000115.md) | [140 d](/filings/0001535929-26-000043.md) | [182](/filings/0001535929-26-000083.md) | [94.0](/filings/0001535929-26-000157.md) |
| Diluted EPS | $ per share | [2.29](/filings/0001535929-24-000103.md) | not reported | [2.24](/filings/0001535929-25-000040.md) | [1.96](/filings/0001535929-25-000071.md) | [0.98](/filings/0001535929-25-000115.md) | not reported | [1.42](/filings/0001535929-26-000083.md) | [1.66](/filings/0001535929-26-000157.md) | [1.80](/filings/0001535929-25-000115.md) | not reported | [1.75](/filings/0001535929-26-000083.md) | [0.97](/filings/0001535929-26-000157.md) |
| Basic EPS | $ per share | [2.35](/filings/0001535929-24-000103.md) | not reported | [2.29](/filings/0001535929-25-000040.md) | [2.00](/filings/0001535929-25-000071.md) | [1.00](/filings/0001535929-25-000115.md) | not reported | [1.45](/filings/0001535929-26-000083.md) | [1.69](/filings/0001535929-26-000157.md) | [1.82](/filings/0001535929-25-000115.md) | not reported | [1.78](/filings/0001535929-26-000083.md) | [0.99](/filings/0001535929-26-000157.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [149](/filings/0001535929-23-000081.md) | [157](/filings/0001535929-25-000017.md) | [162](/filings/0001535929-24-000050.md) | [161](/filings/0001535929-24-000083.md) | [167](/filings/0001535929-24-000103.md) | [164](/filings/0001535929-26-000043.md) | [164](/filings/0001535929-25-000040.md) | [172](/filings/0001535929-25-000071.md) | [177](/filings/0001535929-25-000115.md) | [179](/filings/0001535929-26-000157.md) | [173](/filings/0001535929-26-000083.md) | [183](/filings/0001535929-26-000157.md) |
| Total liabilities | $bn | [144](/filings/0001535929-23-000081.md) | [151](/filings/0001535929-25-000017.md) | [156](/filings/0001535929-24-000050.md) | [155](/filings/0001535929-24-000083.md) | [160](/filings/0001535929-24-000103.md) | [158](/filings/0001535929-26-000043.md) | [158](/filings/0001535929-25-000040.md) | [166](/filings/0001535929-25-000071.md) | [170](/filings/0001535929-25-000115.md) | [172](/filings/0001535929-26-000157.md) | [167](/filings/0001535929-26-000083.md) | [176](/filings/0001535929-26-000157.md) |
| Long-term debt | $bn | [2.1](/filings/0001535929-23-000081.md) | [2.1](/filings/0001535929-25-000017.md) | [1.7](/filings/0001535929-24-000050.md) | [1.7](/filings/0001535929-24-000083.md) | [2.1](/filings/0001535929-24-000103.md) | [2.1](/filings/0001535929-26-000043.md) | [2.1](/filings/0001535929-25-000040.md) | [1.7](/filings/0001535929-25-000071.md) | [1.5](/filings/0001535929-25-000115.md) | [1.5](/filings/0001535929-26-000157.md) | [1.9](/filings/0001535929-26-000083.md) | [2.0](/filings/0001535929-26-000157.md) |
| Current portion of debt | $bn | [0.0](/filings/0001535929-23-000081.md) | [0.0](/filings/0001535929-25-000017.md) | [0.4](/filings/0001535929-24-000050.md) | [0.4](/filings/0001535929-24-000083.md) | [0.4](/filings/0001535929-24-000103.md) | [0.4](/filings/0001535929-26-000043.md) | [0.0](/filings/0001535929-25-000040.md) | [0.4](/filings/0001535929-25-000071.md) | not reported | [0.6](/filings/0001535929-26-000043.md) | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001535929-23-000081.md) | [0.0](/filings/0001535929-25-000017.md) | [0.4](/filings/0001535929-24-000050.md) | [0.4](/filings/0001535929-24-000083.md) | [0.4](/filings/0001535929-24-000103.md) | [0.4](/filings/0001535929-26-000043.md) | [0.0](/filings/0001535929-25-000040.md) | [0.4](/filings/0001535929-25-000071.md) | [0.6](/filings/0001535929-25-000115.md) | [0.6](/filings/0001535929-26-000157.md) | [0.6](/filings/0001535929-26-000083.md) | [0.2](/filings/0001535929-26-000157.md) |
| Shareholders' equity | $bn | [3.1](/filings/0001535929-23-000081.md) | [4.2](/filings/0001535929-25-000017.md) | [4.2](/filings/0001535929-24-000050.md) | [4.0](/filings/0001535929-24-000083.md) | [4.7](/filings/0001535929-24-000103.md) | [4.0](/filings/0001535929-26-000043.md) | [4.4](/filings/0001535929-25-000040.md) | [4.6](/filings/0001535929-25-000071.md) | [5.0](/filings/0001535929-25-000115.md) | [5.0](/filings/0001535929-26-000157.md) | [4.7](/filings/0001535929-26-000083.md) | [4.7](/filings/0001535929-26-000157.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [403 d](/filings/0001535929-24-000103.md) | [364 d](/filings/0001535929-26-000043.md) | [231](/filings/0001535929-25-000040.md) | [316 d](/filings/0001535929-25-000071.md) | [719 d](/filings/0001535929-25-000115.md) | [79.0 d](/filings/0001535929-26-000043.md) | [(179)](/filings/0001535929-26-000083.md) | [742 d](/filings/0001535929-26-000157.md) | [168 d](/filings/0001535929-25-000115.md) | [557 d](/filings/0001535929-26-000043.md) | [(36.0)](/filings/0001535929-26-000083.md) | [503 d](/filings/0001535929-26-000157.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [42.0 d](/filings/0001535929-24-000103.md) | [42.0 d](/filings/0001535929-26-000043.md) | [41.0](/filings/0001535929-25-000040.md) | [43.0 d](/filings/0001535929-25-000071.md) | [44.0 d](/filings/0001535929-25-000115.md) | [43.0 d](/filings/0001535929-26-000043.md) | [43.0](/filings/0001535929-26-000083.md) | [47.0 d](/filings/0001535929-26-000157.md) | [43.0 d](/filings/0001535929-25-000115.md) | [45.0 d](/filings/0001535929-26-000043.md) | [44.0](/filings/0001535929-26-000083.md) | [46.0 d](/filings/0001535929-26-000157.md) |
| Share repurchases | $m | [50.0 d](/filings/0001535929-24-000103.md) | [157 d](/filings/0001535929-26-000043.md) | [172](/filings/0001535929-25-000040.md) | [176 d](/filings/0001535929-25-000071.md) | [172 d](/filings/0001535929-25-000115.md) | [120 d](/filings/0001535929-26-000043.md) | [0.0](/filings/0001535929-26-000083.md) | [0.0 d](/filings/0001535929-26-000157.md) | [100 d](/filings/0001535929-25-000115.md) | [100 d](/filings/0001535929-26-000043.md) | [150](/filings/0001535929-26-000083.md) | [150 d](/filings/0001535929-26-000157.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [106](/filings/0001535929-23-000081.md) | [110](/filings/0001535929-24-000050.md) | [110](/filings/0001535929-24-000083.md) | [108](/filings/0001535929-24-000103.md) | [105](/filings/0001535929-25-000040.md) | [102](/filings/0001535929-25-000071.md) | [100](/filings/0001535929-25-000115.md) | [97.8](/filings/0001535929-26-000083.md) | [97.7](/filings/0001535929-26-000157.md) | [97.4](/filings/0001535929-25-000115.md) | [94.5](/filings/0001535929-26-000083.md) | [92.3](/filings/0001535929-26-000157.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 90,596,349 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001535929-26-000157.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.